Unified Patent Court Rules Enanta Pharmaceuticals, Inc. Patent EP 4 051 265 Invalid

Enanta Pharmaceuticals, Inc. announced that on October 29, 2026, the Unified Patent Court of the European Union released its decision concluding that European Patent No. EP 4 051 265 is invalid. The court also determined that the patent infringement action was unfounded in light